Biden calls on parents to vaccinate their children after approval of the vaccine in adolescents 12-15 years old

Vaccinate their children against COVID-19 after approval by the Government Advisory Committee of its urgent use Pfizer / BioNTech vaccine US President Joe Biden called parents for 12- to 15-year-olds.

Now that the vaccine has been approved for ages 12 and up, I encourage parents to make sure they get it. vaccine their children, Biden said.

“This is another giant step in our fight against the pandemic.”

Many U.S. states are expected to begin immunizing children between the ages of 12 and 15 with the Pfizer / BioNTech vaccine as early as this week, after the Centers for Disease Control and Prevention (CDC) Advisory Committee unanimously approved an extension of the license use for this age group.

On Monday, the US Food and Drug Administration (FDA) had already approved the use of this vaccine for adolescents aged 12 to 15 years, offering relief to parents who want to send their children back to school and in the summer camps, as broadcast by AMPE. The approval of the vaccine for this age group by the CDC Advisory Board is an important, though not necessary, seal of prior approval by the federal regulator.

Some states, including Georgia, Delaware and Arkansas, began offering the vaccine to the age group on Tuesday, and California’s main COVID-19 website says families can start dating. for their children of this age from today Thursday.

The Advisory Committee on Immunization Practices (ACIP), which provides recommendations to the CDC, voted yesterday 14-0 in favor of the use of the vaccine in children aged 12-15 years after evaluating the test data. These indicate that none of the children in this age group who received the Pfizer / BioNTech vaccine were infected with COVID-19 and that there were no cases of facial nerve palsy (Bell’s palsy) or severe allergic reactions.

In addition the vaccine elicited a strong response to antibody generation in this age group and showed 100% efficacy in the trial, as no case of symptomatic COVID-19 was recorded among fully vaccinated adolescents.

This will provide protection for 12- to 15-year-olds, said Dr. Henry Bernstein, who is a member of the advisory committee and professor of pediatrics at Huffstra / Northwell University’s Zucker School of Medicine. “This will reduce transmission within the family. “It will help immunize the community and allow children to return safely to camps this summer and to physical schools.”

Making the vaccine available to teens will help limit the spread of the new coronavirus at a time when more contagious strains of the virus are circulating, and could pave the way for a return to normal life for Americans.

Pfizer is conducting a separate clinical trial for this vaccine in young children up to 6 months of age and has announced that it expects to have data for children aged 2 to 11 years in September. The 2,260 teens surveyed for the 12-15 age group – half of whom were given placebo – were tested in an extension of a Pfizer test involving more than 46,000 people.

You may also like